INmuneBIO

La Jolla, United States

INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.

$19.0M raised

Jun 2025

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has INmuneBIO raised?

INmuneBIO has raised $19.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.

Who are INmuneBIO's investors?

INmuneBIO's investors include Silicon Valley Bank, Alector, Toucan Capital.

Where is INmuneBIO headquartered?

INmuneBIO is headquartered in La Jolla, United States.

What does INmuneBIO do?

INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.

What stage is INmuneBIO at?

INmuneBIO is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 27, 2025.

MLA

"INmuneBIO — Funding & Investors." VCBacked, June 27, 2025, https://www.vcbacked.co/company/inmunebio. Accessed July 2, 2026.

APA

VCBacked. (2025). INmuneBIO — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/inmunebio

Wikipedia (cite web)

{{cite web |title=INmuneBIO — Funding & Investors |url=https://www.vcbacked.co/company/inmunebio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 27, 2025.